Inhaled insulin Afrezza has launched in India, offering a needle-free option for diabetes management. Designed to overcome ...

Inhaled insulin, a patient-friendly alternative to injections, has been introduced in India. This new method aims to alleviate 'needle phobia' and improve diabetes management.

MannKind closed 2025 on a high note, marked by milestones that reinforce our growth trajectory—including the acquisition of scPharmaceuticals and a record-setting fourth quarter surpassing $100 ...

Blowing oxygen into molten steel in vacuum conditions saves time and money when compared to conventional steelmaking methods.

Estimated YUTREPIA™ net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year ...

Six puppies were saved from a suspected fentanyl overdose in Gold Bar on Sunday by Sky Valley Fire (SFV) crews.

"Angle Advisors played a critical role in the successful sale of Forecast 3D, bringing both industry insight and rigorous transaction execution. Their team managed a complex process with ...

At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, ...

Bareilly: The son of jailed Ittehad-e-Millat Council (IMC) chief Maulana Tauqeer Raza Khan was detained by police in ...

Estimated YUTREPIA net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year 2025Received more than 2,800 unique patient prescriptions since launch in Jun ...

Liquidia (LQDA) rebounds after YUTREPIA FDA approval and $51.7M sales, but inventory effects, demand uncertainty, and patent ...

Caplacizumab is a von Willebrand factor (vWF)-directed antibody fragment designed to inhibit the interaction between vWF and platelets.